J. Tartaglia

ALVAC-SIV-<i>gag</i>-<i>pol</i>-<i>env</i>-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIV_mac-Induced Immunodeficiency

R Pal, David Venzon, Norman L. Letvin et al. · Journal of Virology · 2002 · 230 citations · Full text

Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene

Michael A. Egan, William A. Pavlat, J. Tartaglia et al. · The Journal of Infectious Diseases · 1995 · 101 citations

Induction of Cytotoxic T Lymphocytes by Recombinant Canarypox (ALVAC) and Attenuated Vaccinia (NYVAC) Viruses Expressing the HIV-1 Envelope Glycoprotein

William I. Cox, J. Tartaglia, Enzo Paoletti · Virology · 1993 · 95 citations

Vaccination, Recombinant Canarypox, Cytotoxic T Lymphocytes +10

Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)

T-M Jourdier, Catherine Moste, M-C Bonnet et al. · Gene Therapy · 2003 · 81 citations · Full text

Veterinary Vaccine, Interleukin 2, Medicine +8

Highly Attenuated HTLV Type I <i>env</i> Poxvirus Vaccines Induce Protection against a Cell-Associated HTLV Type I Challenge in Rabbits

Genoveffa Franchini, J. Tartaglia, P. D. Markham et al. · AIDS Research and Human Retroviruses · 1995 · 52 citations